Legal Representation
Attorney
Brent R. Bellows
USPTO Deadlines
Next Deadline
1102 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230131)
Due Date
January 31, 2029
Grace Period Ends
July 31, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 31, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 31, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 15, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 15, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 26, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 13, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 13, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 13, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 13, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 13, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 12, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 21, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jan 20, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 17, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development in the field of gene therapy, namely, the research and development of gene therapy pharmaceutical compositions for use in treating genetic disorders in human patients by targeting gene insertion into the liver
First Use Anywhere:
Sep 9, 2021
First Use in Commerce:
Sep 9, 2021
Additional Information
Design Mark
The mark consists of the wording "IECURE" in purple stylized font wherein the letter "i" is lower case and forms the horizontal middle line of the letter "E" in the colors purple, pink, and orange, wherein the dot in "i" is oriented on the left side of the "E". The letter "U" is formed by a depiction of a double helix DNA molecule in the colors purple, pink, and orange, with the lower portion of the helix gradually faded.
Color Claim
The colors purple, orange, and pink are claimed as a feature of the mark.
Translation
The English translation of "IECUR" in the mark is "liver".
Pseudo Mark
ECURE
Classification
International Classes
042